JAK-STAT signaling is a crucial transducer in cardiomyocytes hypoxia injury (60), cancer (61), hematopoiesis and leukemia (62), rheumatoid arthritis (63), acute lung injury (64), central nervous system disorders (65), and obesity and diabetes (66). Here, SOAT1 is linked to leukemia.